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Two recent studies shed light onmechanisms underlyingmuscle dysfunction in age and disease. They reveal
that JAK-STAT signaling regulates myogenic differentiation, leading to a reduced reservoir of muscle stem
cells. Both genetic and pharmacologic inhibition of STAT3 signaling improve stem cell homeostasis and
physiology of aged and dystrophic muscles.STAT3 belongs to a downstream sig-
naling pathway of a series of receptors,
which include receptors for IL6, HGF,
IL15, and EGF (reviewed in Yin et al.,
2013, Brack andRando, 2012), expressed
by myogenic cells during myogenesis.
Regenerative capacities of muscle stem
cells, or satellite cells, decline with age.
Extrinsic/environmental cues have been
implicated in this process (reviewed in
Brack and Rando, 2012), which is not sur-
prising given the tight interactions muscle
stem cells develop with the microenviron-
ment, including immune cells (Mounier
et al., 2011; Paylor et al., 2011). However,
recent studies have shown that alter-
ations in intrinsic cell signaling also
contribute to the declined functionality of
aged satellite cells. Two papers recently
published in Nature Medicine (Tierney
et al., 2014; Price et al., 2014) now identify
a specific role for JAK-STAT3 signaling in
muscle stem cells in inducing myogenic
differentiation to the detriment of their
expansion. They also show that this
pathway predominates in aged and
dystrophic muscle stem cells, providing
a new molecular mechanism regulating
muscle stem cell homeostasis and an
opportunity for therapeutic targeting.
The study from the Sacco team shows
that silencing STAT3 in myogenic stem
cells increases their expansion both
in vitro and in vivo and results in an in-
crease of Pax7pos stem cells in the mus-
cle. The increased number of muscle
stem cells correlates with a decreased
size of the newly formed myofibers as a
result of an altered choice between
expansion and differentiation during mus-
cle regeneration. Tierney et al. (2014)
further investigated the in vivo effects
of pharmacological inhibition of STAT3signaling. A single—and thus transient—
inhibition of STAT3 just after injury triggers
the acceleration of the regeneration pro-
cess in both adult and aged animals.
Moreover, they show that weekly injec-
tions of the STAT3 inhibitor improve
the phenotype of dystrophic muscle.
At the molecular level, STAT3 activity
stimulates Myod1 expression through
binding to a specific locus upstream its
transcriptional start site, marked by his-
tone H3Lys27 acetylation, indicative of
its activation.
The study from the Rudnicki lab (Price
et al., 2014) focuses on the JAK2-STAT3
pathway in muscle stem cells during
aging. Interestingly, activation of the
pathway, including phosphorylation of
STAT3 itself and the expression of down-
stream genes, increases with age in
myogenic (Pax7pos) cells. Meanwhile, the
capacity of these cells to engraft into
dystrophic muscle decreases with age.
Upon transplantation, purified Pax7pos
cells that have been ex vivo silenced for
STAT3 (by either siRNA or treatment with
STAT3 inhibitors) engraft much better
than untreated cells with the strongest
effect on cells isolated from the oldest
mice. Similar to results obtained in the
study of Tierney et al. (2014), intramus-
cular injection of STAT3 inhibitors soon
after injury leads to accelerated muscle
regeneration associated with an in-
creased number of Pax7pos cells in the
muscle. Interestingly, Price et al. (2014)
have investigated the effects of STAT3
inhibition at the cellular level in the
floating myofiber model using the Myf5-
cre;R26R-YFP strain in which 10% of the
Pax7pos cells are Myf5neg, thereby placing
themupstream in themyogenic hierarchy.
STAT3 inhibition (through siRNA orCell Stem Cell 1pharmacological inhibitors) triggers an in-
crease of the planar divisions of muscle
stem cells, leading to a final increase of
the number of stem cells, to the detriment
of apico-basal divisions that give rise to
cells committed into myogenesis. Here
again, the effects of STAT3 inhibition are
more pronounced on stem cells derived
from older animals.
Taken together, these two studies
define a role for the JAK-STAT3 signaling
pathway in the control of muscle stem
cell expansion at the time of muscle
regeneration, adding a function to this
pathway known to control the fate of
various stem cells. STAT3 is required
for self-renewal and pluripotency of em-
bryonic stem cells (Raz et al., 1999.) In
the hematopoietic system, STAT3 plays
a key role in stem cell homeostasis as
well as in the production and maturation
of different types of immune cells,
including granulocytes (reviewed in
Hankey, 2009). Interestingly, STAT3 is
required for increasing and accelerating
granulocyte production during emer-
gency granulopoiesis (Zhang et al.,
2010). Similarly, constitutively activated
Stat3 promotes hematopoietic stem cell
expansion but only under regenerative,
and not homeostatic, conditions (re-
viewed in Hankey, 2009). Thus, a com-
pendium of publications now highlights
STAT3 as a crucial mediator of cell
regeneration under severe stress condi-
tions. In this line, IL6-STAT3 signaling
has been recently shown to enhance
the regeneration of airway epithelium
after inhalation injury (Tadokoro et al.,
2014).
Further investigations should integrate
the specific role of STAT3 signaling with
those of Wnt and Notch, which are crucial5, October 2, 2014 ª2014 Elsevier Inc. 401
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homeostasis and also subjected to alter-
ation with age (Yin et al., 2013). A deregu-
lated (activated) JAK-STAT signaling in
stem cells from aged or diseasedmuscles
exemplifies the tight links between envi-
ronmental cues and stem-cell-autono-
mous defects. As shown by the GO anal-
ysis in the paper by Price et al. (2014),
satellite cells from 18-month-old mice
mainly display the expression of genes
associated with immune response,
vasculature development, and wound
healing, which are all characteristics of in-
flamm-aging. Ultimately, the goal of such
efforts is to define therapeutic targets by
dissecting the specific environmental
cues leading to altered cell-autonomous
signaling pathways and particularly the
epigenetic alterations triggered by a pro-
longed exposure to an inflammatory envi-402 Cell Stem Cell 15, October 2, 2014 ª201ronment. The papers by the Sacco and
Rudnicki groups show that STAT3 medi-
ates proinflammatory signals that shift
the balance of muscle stem cell activity
toward their differentiation under the
chronic inflammatory conditions estab-
lished during aging and therefore reduces
their regenerative potential. These studies
pave the way toward pharmacological
intervention targeting STAT3 activity to
improve muscle regeneration in sarcope-
nia or muscular dystrophies.
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